Farallon Capital Management LLC Liquidia Corp Transaction History
Farallon Capital Management LLC
- $19.9 Billion
- Q3 2024
A detailed history of Farallon Capital Management LLC transactions in Liquidia Corp stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,290,956 shares of LQDA stock, worth $38.1 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
3,290,956
Previous 2,055,000
60.14%
Holding current value
$38.1 Million
Previous $24.7 Million
33.45%
% of portfolio
0.17%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding LQDA
# of Institutions
171Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$83.1 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$49.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$39.8 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$36.9 Million16.08% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$26.2 Million1.86% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $745M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...